Tafluprost and Atrial fibrillation/flutter - a phase IV clinical study of FDA data

Summary:

Atrial fibrillation/flutter is reported as a side effect among people who take Tafluprost (tafluprost), especially for people who are male, 60+ old, also take Folic Acid, and have High blood pressure.

The phase IV clinical study analyzes which people have Atrial fibrillation/flutter when taking Tafluprost. It is created by eHealthMe based on reports of 458 people who have side effects when taking Tafluprost from the FDA, and is updated regularly.

What is Tafluprost?

Tafluprost has active ingredients of tafluprost. eHealthMe is studying from 459 Tafluprost users. Check the latest studies of Tafluprost.

What is Atrial fibrillation/flutter?

Atrial fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles) is found to be associated with 2,362 drugs and 3,843 conditions by eHealthMe. Check the latest studies of Atrial fibrillation/flutter.

On Aug, 02, 2026

458 people reported to have side effects when taking Tafluprost.
Among them, 16 people (3.49%) have Atrial fibrillation/flutter.

Could Tafluprost cause Atrial fibrillation/flutter?

Among these 16 people:

What is the gender of people who have Atrial fibrillation/flutter when taking Tafluprost? *

female: 40 %
male: 60 %

What is the age of people who have Atrial fibrillation/flutter when taking Tafluprost? *

What are other drugs people take besides Tafluprost? *

What are other side effects people have besides Atrial fibrillation/flutter? *

Dyspnea (difficult or laboured breathing): 13 people, 81.25%
Idiopathic Pulmonary Fibrosis (chronic lung disease): 11 people, 68.75%
Wound Abscess (pus in wound): 10 people, 62.50%
Lymph Follicular Hypertrophy (an increase in the size of the lymph node follicles): 10 people, 62.50%
Glaucoma (increased fluid pressure in the eye with vision loss): 10 people, 62.50%
Emphysema (chronic respiratory disease - over inflation of the air sacs (alveoli) in the lungs): 10 people, 62.50%
Hepatic Steatosis (fatty liver disease): 10 people, 62.50%
Hoarseness Or Changing Voice: 10 people, 62.50%
Type 2 Diabetes: 10 people, 62.50%
Intervertebral Disc Degeneration (spinal disc degeneration): 10 people, 62.50%

What are the existing conditions these people have? *

High Blood Pressure: 11 people, 68.75%
Stress And Anxiety: 3 people, 18.75%
Platelet Count Increased: 3 people, 18.75%
Malignant Melanoma (skin cancer rises from melancytes): 3 people, 18.75%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 18.75%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 12.50%
Osteoporosis Post-Menopausal (weak bone with possibility to break after stopped menstrual cycles): 1 person, 6.25%
Osteoporosis (bones weak and more likely to break): 1 person, 6.25%
High Blood Cholesterol: 1 person, 6.25%
Glaucoma (increased fluid pressure in the eye with vision loss): 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Tafluprost and have Atrial fibrillation/flutter?

- Check whether Atrial fibrillation/flutter is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Tafluprost:

Tafluprost (459 reports)

Browse all side effects of Tafluprost:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Atrial fibrillation/flutter:

Atrial fibrillation/flutter (2,362 drugs)

Browse all the conditions that are associated with Atrial fibrillation/flutter:

Atrial fibrillation/flutter (3,843 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on tafluprost (the active ingredients of Tafluprost) and Tafluprost (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.